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Nuclear localization signalThe prion protein (PrP)—known for its central role in transmissible spongiform encephalopathies—has been
reported to possess two nuclear localization signals and localize in the nuclei of certain cells in various forms.
Although these data are superﬁcially contradictory, it is apparent that nuclear forms of the prion protein can
be found in cells in either the healthy or the diseased state. Here we report that Shadoo (Sho)—a member of
the prion protein superfamily—is also found in the nucleus of several neural and non-neural cell lines as
visualized by using an YFP-Sho construct. This nuclear localization is mediated by the (25-61) fragment of
mouse Sho encompassing an (RXXX)8 motif. Bioinformatic analysis shows that the (RXXX)n motif (n=7-8)
is a highly conserved and characteristic part of mammalian Shadoo proteins. Experiments to assess if Sho en-
ters the nucleus by facilitated transport gave no decisive results: the inhibition of active processes that require
energy in the cell, abolishes nuclear but not nucleolar accumulation. However, the (RXXX)8motif is not able to
mediate the nuclear transport of large fusion constructs exceeding the size limit of the nuclear pore for passive
entry. Tracing the journey of various forms of Sho from translation to the nucleus and discerning the potential
nuclear function of PrP and Sho requires further studies.
© 2013 Published by Elsevier B.V.1. Introduction
Transmissible spongiform encephalopathies are a group of rare,
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sevier B.V.deer and elk [1,2]. The infectious agent contains an improperly folded
form of the host-encoded prion protein (PrPC). Conversion of PrPC into
the disease-associated isoform, termed PrPSc, is thought to be the primary
pathogenic event, although the mechanisms by which the conversion to
PrPSc causes disease are poorly understood [3]. Deciphering the physio-
logical role of PrP may hold a key to this question; however, despite
intensive research over decades, the exact physiological function of the
prion protein remains unclear.
PrP is expressed throughout the body, but in varying amounts;
the highest levels occur in the central nervous system (CNS) and
the heart [4]. It has been alleged to associate with more than ﬁfty
interacting partner molecules [5,6] and its involvement in copper
homeostasis, neuroprotection and signaling, memory, proliferation,
differentiation, apoptosis, myelination, circadian rhythm, cell adhe-
sion, synaptic activity, etc. [5,7,8] has been proposed. However, it is
not clear which, if any, of these functions can explain the conserved
occurrence of PrP across many species including mammals, birds,
ﬁshes and amphibians. To attribute such a function to PrP, Shadoo,
the newestmember of the prion superfamilymayprovide somehint [9].
The Shadoo protein (Shadow of Prion Protein, SPRN gene), was
discovered in silico by Premzl et al. in 2003. They noted that the struc-
ture of the predicted Shadoo protein loosely resembles the ﬂexibly
disordered N-terminal part of the prion protein. In particular there
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unstructured N-terminus: i) a series of tandem repeats of short se-
quences with positively charged residues (from aa. 26 to aa. 48 in
mouse Shadoo, termed XXRG tetrarepeats, and from aa. 51 to aa. 90 in
mouse PrP); ii) and a hydrophobic domain (HD) (from aa. 63 to aa. 82
inmouse Shadoo and fromaa. 111 to aa. 130 inmouse PrP). Thepredicted
subcellular localization of both proteins is the same—i.e. both possess
glycophosphatidyl-inositol (GPI) anchor signal sequences and one or
twoN-glycosylation sites that are suggestive of their release to the secre-
tory pathways—laying further emphasis on their similarity [9,10].
The presence of the GPI anchor and N-glycosylation were experi-
mentally demonstrated on recombinant Sho constructs with or
without a tag as well as on the endogenous protein in brain
homogenates [11,12].
Besides these structural similarities, several other analogies have
been identiﬁed between PrP and Sho.
Their expression reaches its highest levels in the CNS [4,9,10,12].
Endoproteolysis close to the center of PrP generates C1 and N1
fragments which likely have important biological properties [13,14].
C-terminal fragment of Sho resembling PrP's C1 is readily detected
in brain samples and in the cell-associated fraction from lysed cul-
tured cells [12]. Besides these data, PrP endoproteolysed adjacent to
the GPI anchor that releases a nearly full length form of the molecule
which can be reproduced in vitro by ADAM 10 [15,16]. Likewise, a
glycosylated form of Sho is easily detectable within the conditioned
medium of Sho expressing cells [17].
Functional analogies have also been conﬁrmed: the toxic effect of
the third prion protein superfamily member, Doppel, and internal dele-
tion mutant forms of PrP could be counteracted by the co-expression
of either PrP or Sho in transfected granule cell neurons. This rescue
effect was abolished by the deletion of the HD region [12]. Tatzelt and
co-workers reached to a similar conclusion investigating the rescue
effect of the expression of PrP or Sho on kainate or glutamate induced
apoptosis in SH-SY5Y cells. These rescue effects could also be abolished
by the deletion of the HD region [18,19]. In addition, some experiments
on PRNP-knockoutmice suggest that the two proteins have overlapping
functions and can complement each other [20,21], although this issue is
rather controversial [22,23].
To further strengthen the argument for the similarity between
these two proteins, formation of homodimers of both PrP and Sho
have been demonstrated when expressed in cell culture. These asso-
ciations are facilitated by the HD region in the case of both proteins.
Furthermore the formation of heterodimers between PrP and Sho
mediated also by the HD region has also been shown [6,18,19,24].
In addition to this protein-protein interaction, more than a dozen
proteins outside the prion protein superfamily have been identiﬁed
that might interact with both PrP and Sho [6,25]. The similarity be-
tween their binding partners appears to go beyond protein-protein
interactions: nucleic acids have also been shown to bind PrP [26–28]
and it has also been proposed that they bind Sho as well [29]. Sho's
tetrarepeats include an RGG box motif which is present in RNA-
binding proteins involved in various aspects of RNA processing as well
as mediating interactions to other proteins [29].
An overlap in the subcellular distribution pattern of minor pop-
ulations of PrP and Sho, would further buttresses the case for the
functional analogy between these two proteins. PrP has been shown
to have two short sequences, referred to as NLS1 and NLS2 that,
under some conditions, function as nuclear localization signals (NLS)
[30,31]. Various forms of PrP, such as PrPSc [32], truncated PrPs
representing prion proteins with familial mutations [33], or PrP
expressed without endoplasmic reticulum (ER)-targeting signal se-
quences and GPI anchor by genetic engineering [34] or by alternative
translation initiation [35,36] have been demonstrated to appear in both
the cytosol and nucleus. In addition, cellular PrP has been reported in
the nucleus of proliferating epithelial cells [37] as well as in endocrine
and neuronal cells [38]. In line with these observations, Sho has apotential arginine-methylation site that is a common post-translational
modiﬁcation in RGG-box domains and occurs on proteins that are
found in the nucleocytoplasmic compartment [29]. More interestingly,
the endogenous Shadoo appears in the cell bodies of some of the hypo-
thalamic neurons and it was found in nuclear fractions of both brain
and cultured cells [22].
Here we observed a ﬂuorescent tagged form of Sho in the nucleus
of several cell lines, and found nuclear localization signals in the se-
quence of Sho by PredictNLS [39] and by NLStradamus [40]. These
have prompted us to experimentally validate whether any of these
sequences functions as an NLS: which in turn would not only add
one more item to the growing list of similarities between PrP and
Sho, but might also point to a common function of PrP and Sho in
the nucleocytoplasmic compartment.2. Materials and methods
Chemicals: The chemicals usedwere purchased fromSigma-Aldrich,
unless otherwise stated.2.1. Plasmid constructions
To generate YFP-, and GFP-chimeric Shadoo constructs, generally
the N-terminal NheI and AgeI restriction sites (to insert ER-targeting
signals or Shadoo core sequences), and the C-terminal EcoRI and BamHI
restriction sites (to insert Shadoo, GPI-anchor signal, potential NLS
sequences) were used in pEYFP-C1 and pEGFP-C1 (Clontech) respec-
tively. GFP-β-Gal andNLSx3SV40-GFP-β-Galwere kind gifts of Y. Lazebnik.
To generate Sho-GFP-β-Gal and (25-61)Sho-GFP-β-Gal XhoI and XbaI
restriction sites were used. More details for plasmid constructions are
provided in the supplementary documents (Supp. Table 1). Restriction
enzymeswere brought from Fermentas. The deletionmutants were gen-
erated by Quickchange Mutagenesis (Stratagene). All constructs were
veriﬁedby sequencing before beingused. The synthesis of the oligonucle-
otides used and the sequencing of the DNA constructs were carried out
by Microsynth AG (http://microsynth.ch/).2.2. Cell culture
Cells (HeLa, SH-SY5Y, Cos-7, Zpl2-1, Zw3-5, Hpl3-4 and Hw13-3)
were grown at 37 °C in a humidiﬁed atmosphere of 5% CO2 in high-
glucose Dulbecco's Modiﬁed Eagle medium (DMEM, Lonza) sup-
plemented with 10% heat inactivated fetal bovine serum (Lonza) and
containing 100 units/ml penicillin and 100 μg/ml streptomycin (Lonza).
K562 cellswere cultured in Roswell ParkMemorial InstituteMedium
(RPMI)-1640 medium supplemented with 2.0 g/l sodium-bicarbonate,
10% fetal bovine serum (Lonza) and 1% GlutaMAX (Gibco).
Zpl2-1, Zw3-5 [41], Hpl3-4 and Hw13-3 [42] are immortalized,
hippocampal cell lines, they were kind gifts of Y. S. Kim and T. Onodera
respectively.2.3. Transfection
Cells were cultured on Labtek II 8 well chambers (Labtek) or 6
well plates (Greiner Bio-One), seeded a day before the transfection
at a density of 2×104 cells/well or 3×105 cells/well respectively.
The next day, at around 50% conﬂuence, cells were transiently
transfected with plasmid constructs using Turbofect (Fermentas),
brieﬂy as follows: DMEM was changed on the cells to fresh one,
containing 10% FBS. Typically 500 ng/4000 μg plasmid and 0.5 μl/4 μl
Turbofect wasmixed in 50 μl/400 μl serum free DMEM and themixture
was incubated for 40 min at RT prior adding to cells. Transfectionmedi-
umwas changed to fresh supplemented DMEM after 3 h of incubation.
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Chilling and deoxy-glucose treatment were performed as described
by Chatterjee and Stochaj [43]. Brieﬂy, cellswerewashedwith PBS, then
chilled for 2 h at 4 °C followed by 2 h on ice. For 2-deoxy-D-glucose
(DEG) treatment, after washing with PBS, cells were incubated in PBS
containing 10 μM DEG and 10 μM NaN3 (Fluka) for 1 h at RT.
2.5. Confocal microscopy
Cells were ﬁxed using 4% paraformaldehyde in PBS for 10 min, the
cells were then washed with PBS containing Hoechst33342 (5 μM)
(Invitrogen).
Confocal laser scanning microscopy was performed using an
Olympus FV1000 confocal laser scanning microscope (Olympus Life
Science Europe GmbH, Hamburg, Germany). Microscope settings are
summarized in the supplementary documents. Picture capturing and
analysis were performed using Fluoroview software (Olympus).
About 20 photos were made to count 100–300 transfected cells
from each well. All experiments were made with at least 3 replicates
for every construct.
2.6. Western blotting
HeLa cells were cultured on 6-well plate and transfected as
described above. The day after transfection cells were washed with
ice-cold PBS, then scraped, centrifuged at 110 rcf for 5 min at 4 °C.
Pellet was resuspended in Harlow buffer (50 mM Hepes pH 7.5;
0.2 mM EDTA; 10 mM NaF; 0.5% NP40; 250 mM NaCl; Proteinase
Inhibitor Cocktail 1:100). Cell lysates in selected samples were di-
gested by PNGase F (Fermentas) for 2 h at 37 °C.
Before SDS gel loading, samples were boiled in Protein Loading Dye
for 5 min at 95 °C then kept at 4 °C for 5 min. Proteins were separated
by SDS-PAGE using 10 or 12% polyacrylamide gels and transferred to
PVDF membrane. Membranes were blocked by 5% non-fat milk
for 2 h. Blots were incubated overnight with primary antibody
(anti-GFP/YFP 1:3,500, Central European Biosystems), and incubated
with anti-rabbit HRP 1:40,000 (Pierce). The signal from detected pro-
teins was visualized by ECL (Immobilon Western HRP Substrate
Luminol Reagent, Millipore).
2.7. Bioinformatics
Sho protein sequences were obtained from the UniProt
Knowledgebase, using “shadoo” and “shadow” search terms. Our ﬁnal
dataset contains Sho proteins from 33 different vertebrate species
(UniProt ACs: A2BDG9, Q5TJB9, Q5BIV6, A2BDJ8, Q1JPW9, A2BDJ9,
A2BDG5, A2BDG0, A2BDG4, C6ETC7, C6ETD1, A0RZB4, C6ETD7, C6ETD2,
C6ETC9, C6ETC6, C7DLK9, C6ETD0, C6ETC8, A6XN32, C5H878, A2BDG2,
A2BDJ4, A2BDG7, Q8BWU1, C6ETC5, Q5BIV7, A2BDG8, A2BDJ5,
A2BDG6, A2BDH0, A2BDG1, Q5BIV9). Initial multiple alignment
on the dataset was performed using Clustal Omega software
(pmid: 21988835). For further reﬁnements and visualization we
used Jalview software (pmid: 19151095), sequence logos were created
by Weblogo online software (http://weblogo.berkeley.edu/logo.cgi,
pmid: 15173120). We used different searching techniques to ﬁnd
homologies to the (RXXX)8 motif region, (i) BLAST search on the
UniProtKB proteins, (ii) pattern based search using PERL scripts,
(iii) pattern based search combined with residue composition ﬁlter-
ing using PERL scripts, (iv) using proﬁle hidden Markov models
(HMMER software package, pmid: 22039361).
2.8. Statistical analysis
In each experiment, the subcellular localization of the constructs
was scored in at least 100 transfected cells in 3 replicates.Subcellular localizations were scored as follows:
• exclusive nuclear: nuclear enchancement with nearly no cytosolic
signal
• enchanced nuclear: nuclear enhancement with cytosolic signal
• nucleus: exclusive nuclear+enhanced nuclear signal
• homogenous: nuclear and cytosolic intensities are equal
• plasma membrane
The normality of the distributions was tested with Kolmogorov–
Smirnov test; since the distribution of the data was normal, Student's
t-test for independent samples was used to check their signiﬁcance
(SPSS 9.0 Statistica Program).
p value: * 0.01bpb0.05; ** 0.001bpb0.01; *** pb0.001.
3. Results and discussion
3.1. Dual subcellular localization: YFP-tagged Shadoo in the secretory
pathway and in the nucleus
To follow the trafﬁc of Sho, ﬂuorescent protein [enhanced yellow
ﬂuorescent protein (YFP)]was fused to either the N-terminal (YFP-Sho)
or the C-terminal (Sho-YFP) side of the Shadoo protein downstream
from the ER-targeting- or preceding the GPI-signal sequence of Sho,
respectively (Fig. 1A). The original methionine of YFP in YFP-Sho was
changed to leucine in order to eliminate the expression of a signal
peptide-less protein form that is observed in several cell lines (Nyeste
and Welker, unpublished results).
Western blot analysis of cell lysates from transfected HeLa cells in-
dicates that a full length fusion protein is detectable in both YFP-Sho
and Sho-YFP-expressing cells. It should be noted that Sho-YFP showed
bands with lower mobility and seems to be more prone to proteolytic
cleavage as observed consistently during repeated experiments
(Fig. 1B). When analyzed by laser-scanning confocal microscopy,
cells expressing Sho-YFP exhibited a localization pattern which is
expected for a GPI-anchored protein: the YFP signal appeared pre-
dominantly in the plasma membrane and in intracellular vesicles
that most likely correspond to ER and Golgi-like structures. The
same localization was observed for the YFP-GPI control protein. By
contrast, YFP-Sho showed a dual localization; beside the plasma
membrane and ER/Golgi-like structures we observed a nuclear signal
in a subset of the cells (Fig. 1B). Interestingly, while some of these
cells exhibited both membrane and nuclear signals, other showed
only nuclear or nuclear/cytosolic ones.
We examined the expression of these constructs exploring several
neural (human: SH-SY5Y, mouse: Zpl 2-1, ZW 3-5, Hpl 3-4, HW 13-3)
and non-neural (human: HeLa, Cos-7, K562) mammalian cell lines,
and observed the same localizations for these constructs as in HeLa
cells (Supp. Fig. 1; data not shown in the case of Sho-YFP and
YFP-GPI). However, the percentage of the cells showing nuclear accu-
mulation in the case of YFP-Sho varied among the cell lines, being
highest in HeLa cells (about 30% of the cells).
In order to facilitate the identiﬁcation of the segment that is
responsible for Shadoo's nuclear accumulation, signal peptide-less
(ΔSS) Shadoo constructs were also generated to direct these fusion
proteins straight to the cytosol, and thus, enhance their nuclear accu-
mulation (Fig. 2A). This strategy is based on our observation that
YFP-Sho's nuclear distribution appears as a diffuse signal throughout
the nucleus with no speciﬁc localization to membrane-like structures,
and on the report that the cytosolic form of PrP accumulates in the
nucleus of N2a cells [34].
Interestingly, both ΔSS-YFP-Sho and ΔSS-Sho-YFP exhibited near
exclusive nuclear localization in the cell lines investigated (Fig. 2B).
The presence or absence of the GPI signal sequences did not affect
the localization of the ER-targeting signal-less constructs (data not
shown). Summing up these results, the position of the YFP tag appar-
ently inﬂuenced the subcellular distribution of the fusion proteins
YFP-Sho
A
Sho-YFP YFP-GPI
SS YFP Shadoo SS SSYFP YFPShadoo
B
YFP-Sho Sho-YFP YFP-GPI
28
36
+ -PNGase F
72
95
55
+ - + -
kDa
17
Fig. 1. Subcellular localization and immune blot pattern of YFP-Sho, Sho-YFP and YFP-GPI. (A) Schematic structures of YFP-Sho, Sho-YFP and YFP-GPI fusion proteins. SS stands for
the ER-targeting signal peptide; GPI-anchor signal sequence is represented by a small light blue box at the C-terminus. Full length (−) and PNGase F digested (+) forms of YFP-Sho,
Sho-YFP and YFP-GPI detected byWestern blot using 12% SDS-PAGE and anti-GFP/YFP antibody dilution of 1:3,500. Sho-YFP consistently showed slightly slower mobility bands and
seemed to be more prone to proteolytic cleavage than YFP-Sho in repeated experiments (B) Confocal microscopy images of YFP-Sho, Sho-YFP and YFP-GPI expressing HeLa cells.
Only YFP-Sho exhibits dual localization (plasma membrane and nuclear). Signals from YFP or Hoechst 33342 dye are shown in green or blue colours, respectively, and the trans-
mitted light images of the corresponding areas are presented as gray pictures. Scalebar represents 10 μm.
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a protein committed to the secretory pathway, YFP-Sho demonstrated a
dual, plasma membrane and nuclear localization (Fig. 1B, Supp. Fig. 1).
Since in the absence of the signal peptide both fusion proteins accumu-
lated in the nucleus, the position of the YFP tag (N- or C-terminal to Sho)
does not affect directly its nuclear targeting (Fig. 2B). Rather, the loca-
tion of the YFP tag seems to be associated with the ability of the fusion
constructs—that are supposedly targeted to the secretory pathway—to
enter the cytosol. One possible explanation for this difference is thatΔ SS-YFP-Sho
A
Δ SS-Sho-YFP 
YFP Shadoo YFPShadoo
36
+PNGase F
55
+
kDa
72
28
95
17
- -
Fig. 2. Subcellular localization and immune blot pattern of ΔSS-YFP-Sho and ΔSS-Sho-YFP. (A
the absence of the ER-targeting signal peptide; GPI-anchor signal sequence is represented
(+) forms of ΔSS-YFP-Sho and ΔSS-Sho-YFP detected by Western blot analysis (12% SDS-PA
mobility bands than ΔSS-YFP-Sho in repeated experiments; (B) Confocal microscopy ima
ΔSS-Sho-YFP exhibits near exclusive nuclear localization. The presence or absence of the GP
(data not shown). Signals from YFP or Hoechst 33342 dye are shown in green or blue c
presented as gray pictures. Scalebar represents 10 μm.Sho-YFP may be more prone to proteolytic degradation than YFP-
Sho (see Fig. 1B). Alternatively, a speciﬁc proteolytic cleavage on
Shadoo may separate its potential NLS from the ﬂuorescent protein.
Indeed, such proteolytic cleavages have been reported to take place
in the case of endogenous Shadoo protein [12]. Experiments to test
this explanation by tagging this proposed N-terminal fragment
with an unrelated epitope were not conclusive (data not shown).
However, when an NLS was inserted between Sho and YFP, following
the putative protease cleavage site, the YFP signal—in agreementB
ΔSS-ShoYFPΔSS-YFP-Sho
) Schematic structures of ΔSS-YFP-Sho and ΔSS-Sho-YFP fusion proteins. ΔSS indicates
by a small light blue box at the C-terminus. Full length (−) and PNGase F digested
GE, anti-GFP/YFP antibody dilution 1:3,500). ΔSS-Sho-YFP consistently showed slower
ges of ΔSS-YFP-Sho and ΔSS-Sho-YFP expressing HeLa cells. Both ΔSS-YFP-Sho and
I signal sequences did not affect the localization of the ER-signal peptide-less constructs
olours, respectively, and the transmitted light images of the corresponding areas are
1203E. Tóth et al. / Biochimica et Biophysica Acta 1833 (2013) 1199–1211with this explanation—appeared in the nucleus (data not shown).
The clariﬁcation of this issue needs further research.
3.2. In silico identiﬁcation of NLS sequences in Sho
To identify the segment of Sho that is responsible for its nuclear
accumulation we ﬁrst analyzed its amino acid sequences by several
software programs designed for the prediction of nuclear localization
signals.
PredictNLS (available through the PredictProtein server, http://www.
predictprotein.org/ [39]) identiﬁed a stretch in the mouse Shadoo
protein from amino acid 28 (arginine) to amino acid 37 (glycine) that
corresponds to one of the 214 NLS sequences in the database with a
consensus sequence: R G/A X(0-2) G/A R G/A X G/A R G/A. This pre-
dicted NLS (short NLS; snls) is a GR-motif type NLS, and was described
in the large ﬁbroblast growth factor (FGF)-2 isoform [44,45]. In
themouse Shadoo sequence, NLStaradamus [40] was also able to identi-
fy an NLS stretch, which is longer but totally overlapping with
the PredictNLS's one: from amino acid 26 (glycine) to amino acid 53
(alanine).
However, PSORT II [46] and PROSITE [47] found no NLS sequences
in Shadoo.
This information was used for designing experiments in Sections
3.3.1 and 3.3.2 aimed at identifying the NLS of Sho.
3.3. Experimental identiﬁcation of a segment in Sho that is responsible for
its nuclear targeting
The identiﬁcation of NLS(s) that direct a protein to the nuclear
compartment of the cells could be a tricky task involving several ca-
veats. Deletion or mutation of a sequence may diminish nuclear local-
ization even when the sequence is not an NLS or not a complete NLS,
by affecting the trafﬁc, maturation or structure of the protein or the
accessibility of the real NLS. Additionally, proteins frequently have
more than one NLS. Thus, a putative NLS may be effective in directing
another protein to the nucleus although its deletion or mutation has
no apparent impact on the nuclear transport of the protein of interest
due to the possible masking effect by another NLS present in the pro-
tein [48,49].
Testing a sequence for its ability to direct a non-related protein to
the nucleus is another complementary approach having its own caveats.
An NLS may not be effective in the context of a non-related protein if
that protein interferes with the accessibility of the NLS. Conversely, a
sequence may be effective in facilitating nuclear localization when at-
tached to another protein, although it does not function in the context
of its own original protein because its accessibility to the nuclear trans-
port machinery is restricted.
The complexity of this task became apparent when one of the
selected positive controls, the extreme N-terminal NLS of the thyroid
transcription factor 1 (NLSTTF1) did not function when attached to a
GFP (data not shown). The sequence of NLSTTF1 was identiﬁed only
by deletions [50] and mutations [51] in the cited references. Which
of the possible pitfalls discussed above caused this discrepancy is
presently not clear. In further experiments the NLS of quaking I-5
protein (qki5) and Simian Vacuolating Virus 40 (SV40) was used as
a positive control.
3.3.1. Deletion constructs
To identify the segment of the Shadoo protein that is responsible for
the nuclear targeting of the YFP-Sho construct, the sequence between
aa. 28 and 38, identiﬁed by PredictNLS (snls) (see 3.2) was deleted
(YFP-ShoΔsnls). In YFP-ShoΔRGG the deletion was extended to include
the full RGG box (from aa. 28 to aa. 41). The RGG-box, the arginine
and glycine rich N-terminal segment of Sho might also result nuclear
localization by virtue of its reported nucleic acid [52] and/or protein
binding capability [53]. In a third construct, we extended the deletionfurther to the whole positively charged N-terminus of Sho (from aa.
25 to aa. 61), that spans the long NLS predicted by NLStaradamus
(YFP-ShoΔ(25–61)). The same segments were deleted in the signal
peptide-less protein ΔSS-YFP-Sho as well.
In YFP-Sho, increasing the length of the deletionswas correlatedwith
a decrease in the number of cells showing nuclear localization that be-
came signiﬁcant (p=0,037, *) with the deletion of the (25–61) segment
that reduced it from about 30% to 0% (Supp. Fig. 2). Deleting the same
segments in the signal peptide-less variant (ΔSS-YFP-Sho), the exclusive
nuclear localization was practically abolished with all three constructs,
although the deletion of the snls or the RGG-box still resulted in about
50% of the transfected cells showing enhanced nuclear signal. The en-
hanced nuclear signal decreased to the control GFP level only when
the whole (25–61) region of Sho was deleted (Fig. 3). Such results are
more straightforward to interpret for a cytosolic protein. However, Sho
is supposed to be synthesized on the rough ER and a deletion could in-
terfere with its ability to get to the cytosol from (or instead of) the secre-
tory pathway, and thus, could indirectly abolish its nuclear transport.
Since the deletion of the (25–61) fragment of Sho causes the same effect
in YFP-Sho and in the ΔSS-YFP-Sho construct that is—in the absence of a
signal sequence—directed directly into the cytosol, this possibility can be
ruled out.
These results therefore suggest that the segment which is respon-
sible for the nuclear targeting of Sho is conﬁned within the (25-61)
region of Sho.
3.3.2. Potential NLS sequences attached to GFP reveal that snls and the
RGG motif do not function as an NLS
To see which, if any, of these segments can function independently
as an NLS, all three deleted segments [snls, RGG-box and (25–61)]
were also fused to the C-terminal of GFP, generating GFP-snlsSho,
GFP-RGGSho and GFP-(25–61)Sho. As a control, NLS of the quaking
I-5 protein [54] was also attached to GFP (GFP-NLSqki5). The vectors
were transfected toHeLa cells alongwithGFP andΔSS-YFP-Sho. Near ex-
clusive nuclear localization were observed only with GFP-(25–61)Sho,
GFP-NLSqki5 and ΔSS-YFP-Sho. Little to no difference to the control GFP
was observable with GFP-snlsSho, GFP-RGGSho (Fig. 4).
One possible pitfall in the interpretation of these experiments
(as was pointed out previously) is that the snls or RGG-box frag-
ments may fail to function in these constructs due to their position
relative to GFP or due to their spacing from GFP. However, aa. 25 to
61 in GFP-(25–61)Sho construct which also contains the snls and
the RGG-box sequences in the same orientation and spacing, does
function as a nuclear targeting signal. These results indicate that
the snls and the RGG-box of Sho are insufﬁcient to direct the fusion
protein to the nucleus, although they are likely to be part of the com-
plete nuclear localization signal of Sho which is contained in the
(25-61) segment.
3.3.3. Role of snls and RGG-box in the nuclear targeting of YFP-Sho
Since the second half (last 24 amino acids) of the (25–61) seg-
ment alone is able to cause YFP to accumulate in the nucleus in
of about 50% of the cells even in the absence of the ﬁrst part
(ΔSS-YFP-ShoΔsnls in Fig. 3), it is possible that only this second part
is involved directly in the nuclear targeting of Sho. Thus the only
function of the ﬁrst part (snls or RGG-box) in these experiments
may be to keep the second part at an appropriate distance from GFP
in constructs where the (25–61) fragment or the full length protein
is attached. We addressed this question by changing the position of
Sho and of all the three Sho deletion mutants from the C-terminal
to the N-terminal end of YFP (Fig. 5). Fig. 5 shows that the last 20 or
24 amino acids of (25–61) in the absence of snls or the RGG-box, re-
spectively, have a reduced ability to drive the fusion protein to the
nucleus. The deletions greatly diminish Sho's nuclear localization, al-
though the distance and orientation of the second half of the (25–61)
segment was not altered in these constructs indicating that the
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ΔSS-YFP-ShoΔ(25–61) and YFP and representative confocal microscopy images of HeLa cells transfected with the above mentioned constructs. The nuclear signal decreased to the
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rescent protein (Fig. 5). These data point to the whole (25–61) seg-
ment of Sho as being the element responsible for Sho's full nuclear
targeting.
It is worth to note that in this region (between aa. 28 and aa. 58) the
precise positions of arginine residues are conspicuous. Between two ar-
ginines, generally three small, predominatly hydrophobe amino acids
[(RXXX)n motif, where X is usually glycine, alanine, valine, serine,
Supp. Fig. 3) hold the distance. Negative amino acids are completely
missing from this region. Eight of these tetrarepeats [(RXXX)8 motif]
could be observed in the N-terminal part of Shadoo in mouse.
3.4. The nature of the nuclear-targeting (RXXX)8 motif of Sho
The NLS of Sho we have identiﬁed resembles to the substrate
of transportin (Karyopherin-β2) that binds natively unstructured
sequences, about 30-amino-acid-long with an overall positive(or hydrophobic) character and an R/K/H X(2-5) P Y sequence in their
C-terminal region. The (RXXX)8 motif of mouse Sho seems to fulﬁl
these requirements except that there is a RPAPRY sequence (aa. 51–56)
instead of a RPAPY terminus. The individual amino acids in a
Karyopherin-β2 substrate make only a small contribution to the
binding energy and the sequence as a whole is relatively insensi-
tive to mutations except for the PY terminus mutation of which
abolishes the binding to Karyopherin-β2 [55]. In order to see if
Sho has a similarly functioning NLS, the contribution of amino acids
52–56 of Sho to the nuclear transport of the fusion constructs was
examined by substituting this sequence with 5 consecutive alanines.
The mutations cause no alteration in the nuclear targeting of YFP-
Sho, ΔSS-YFP-Sho or GFP-(25–61)Sho (data not shown) and give no
support to the putative involvement of this element in nuclear
targeting despite the apparent sequence similarity.
The other most prevalent feature of the (RXXX)8 motif is the
periodically reoccurring arginines. To test if these arginines play a
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mines [GFP-(25–61)RQSho]. The mutations eliminated the nuclear and
nucleolar accumulation of GFP-(25–61)Sho resulting in a homogenous,
GFP-like localization in all of the cells (Supp. Fig. 4) suggesting that
the positively-charged arginines play a crucial role in Shadoo's nuclear
enhancement.
3.5. Bioinformatic analysis shows high evolutionary conservation to the
characteristic (RXXX)n motif of Sho
We observed high sequence conservation and high residue com-
position conservation in the entire (RXXX)n (n=7–8) motif among
the analyzed mammalian Shadoo proteins. Eight of this tetrarepeat
[(RXXX)8] could be observed in the N-terminal part of Shadoo in
the known rodent and homininid Sho sequences; seven repeats
[(RXXX)7] could be observed in the known ruminant sequences, in
chicken's and in Western clawed frog's Sho (Supp. Fig. 3). The multi-
ple alignment data we present show that the ﬁrst part (RGG box)
of the motif is the most conserved part of the whole protein and
according to the sequence logo, the characteristic basic amino acid
bias and residue composition is well conserved in the entire motif(Fig. 6). The previously known functional modules of Sho (ER-targeting
signal sequence, repeat region, RGG box, HD region, GPI signal
sequence) show the same or lower conservation compared to the
identiﬁed (RXXX)n motif. We found, that (RXXX)n is not only a
well conserved region in Shadoo proteins, but also an obligatory
characteristic of these proteins. Using different search strategies,
we were not able to ﬁnd any other protein with a region similar to
the entire motif. If we separated the two parts, and search for simi-
larities to each of them, we found a few proteins with high similarity
to the RGG-box part of the (RXXX)n motif, but the second part re-
mains completely unique. The eukaryotic proteins we found homol-
ogous for the RGG-box part are annotated as having nuclear and/or
nucleolar localization and function (e.g. SwissProt IDs: P83214,
Q6Z1C0, D1Z6B1).
3.6. Transport through the nuclear pore complex driven by the (25–61)
fragment of Sho
Some smaller nuclear proteins (cca. below 60 kDa) can get
through the nuclear pore by diffusion (passive entry) and accumulate
there by binding to a partner. The protein segment involved in the
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cess results in a net accumulation of the protein in the nucleus, it is
also referred to as passive transport. In contrast to passive transport,
many proteins that accumulate in the nucleus exploit an energy-
dependent transport process frequently facilitated by the importin
protein family (the process is referred to as active or facilitated nuclear
transport). Some proteins use both active and passive means to enter
the nucleus. Thus, an NLS sequence which mediates facilitated nuclear
transport may be masked by the presence of an NRS or vice versa.
The same situation may be relevant in the case of Sho. Since, Sho is
small enough to enter freely into the nucleus by passive entry, it could
accumulate there by binding e.g. to nucleic acids through its reported
RGG-box [29]. This effect may not become apparent with the con-
structs we explored above, since deletions that might abolish Sho'sactive nuclear transport might also abolish its nucleic acid binding,
thus its passive transport.
To avoid such pitfalls, we used two approaches: (i) where an NRS
can be detected even in the presence of a facilitated transport-
mediating NLS (see in Section 3.6.1) and (ii) where a facilitated
transport-mediating NLS can be detected even in the presence of
an NRS (see in Section 3.6.2). Both the full-length Sho protein and
its (25–61) fragment in fusion to a ﬂuorescent protein were used
for these purposes.
3.6.1. Testing if the (25–61) segment of Sho contains an NRS
In the ﬁrst approach, chilling the cells for a few hours effectively
slows down all the active transport processes of the cells including nu-
clear transport [43]. Thus proteins small in size that are accumulated in
Fig. 6. Evolutionary conservation of the mammalian Shadoo protein and the newly
described (RXXX)n motif. (A) Five residue long sliding window was used to visualize
the average sequence conservation in the mammalian Sho protein. Known motifs are
indicated by blue boxes above the conservation diagram, red box and grey shading
indicates the position of the identiﬁed (RXXX)n motif (n=7–8). We observed high se-
quence conservation and high residue composition conservation in the entire (RXXX)n
(n=7–8) motif among the analyzed mammalian Shadoo proteins. The number of the
(RXXX) repeats varies among the analyzed taxons. For example the ruminant Shadoo
sequences contain seven (RXXX) tetrarepeat, by contrast the rodent and hominid
Shadoo sequences contain eight (RXXX) tetrarepeats. This difference resulted in a
gap on the A graph, although it does not affect the whole motif conservation. (B) Se-
quence logo of the (RXXX)n motif shows high conservation of tandem basic residues
(mostly arginines), and conservation of the overall residue composition. A more
detailed comparison of the known vertebrate (RXXX)n motifs in different species is
summarized in Supp. Fig. 3.
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by diffusion unless they are retained by binding to a nuclear partner.
HeLa cells were transfected with (i) GFP, i.e. control showing no
nuclear accumulation (data not shown), (ii) GFP-(Cherry)4-NLSSV40,
i.e. control showing the intactness of the nuclear pore during treatment
(iii) GFP-NLSSV40, i.e. positive control showing nuclear accumulation
without possessing an NRS, (iv) NLSx3SV40-GFP, i.e. positive control
showing nuclear accumulation and possessing an NRS (unpublished
result), (v) along with ΔSS-Sho-YFP, ΔSS-YFP-Sho and GFP-(25–
61)Sho. The cells were chilled for 4 h, then ﬁxed and were analyzed by
confocal microscopy for the localization of the fusion proteins (Fig. 7).
Each of the control constructs showed localizations as expected.
All constructs, except GFP showed nuclear accumulation at 37 °C.
However, after 4 h incubation at 4 °C, only GFP-(Cherry)4-NLSSV40
and NLSx3SV40-GFP exhibited a nearly unchanged nuclear accumula-
tion (Fig. 7). Since the NLSSV40 has no binding partner in the nucleus,
the fact that the nuclear accumulation of GFP-(Cherry)4-NLSSV40—that
is too large to freely diffuse in and out of the nucleus—was unchanged,
indicates that the intactness of the nuclear pore was not altered by the
treatment. Interestingly, accumulation of ΔSS-Sho-YFP, ΔSS-YFP-Sho
and GFP-(25–61)Sho in the nucleuswas diminished except in the nucle-
olus which retained its ﬂuorescence and appeared as bright spots
(Fig. 7). The identity of nucleolar localization was conﬁrmed by the
co-localization of the GFP signal with anti-ﬁbrillarin antibody staining
(data not shown).
To avoid any direct effect of the chilling on the binding or on the
conformations of the binding partners, the same experiments were
repeated using 2-deoxy-D-glucose (DEG) and Na-azide treatmentthat slows down the active processes by causing ATP depletion.
These data gave the same results as the chilling experiments (Fig. 7).
3.6.2. Testing whether the (RXXX)8 motif mediates active transport
In a second approach, to check if the (RXXX)8 motif is able to
mediate facilitated nuclear transport, we applied a seemingly easy
test to assess whether Sho's nuclear transport is an active or a passive
process, by increasing the dimensions (molecular weight and shape)
of the fusion proteins above the cut off size of the nuclear pore. Thus,
the passive transport of the fusion proteins is blocked. If a fragment is
still able to mediate the transport of the fusion protein, it must be
transported by means of an active transport process. However, there
are a few considerations with this approach too. The fusion protein
itself, without an NLS should be totally excluded from the nucleus
to rule out passive transport albeit with a slower kinetics. A GFP
dimer works well in yeast that has a smaller size limit for passive
transport through the nuclear pore [49,56]. However, in HeLa cells
we found even three consecutively joined ﬂuorescent proteins
[GFP-(Cherry)2] in the nucleus of a fraction of the cells. For that
reason, we chose 5 consecutive ﬂuorescent proteins GFP-(Cherry)4
for C-terminal attachment along with GFP-β-Gal fusion constructs
for N-terminal attachment [57].
Thus to minimize the probability of an unnoticed interference
from the fusion protein on the function of an NLS we used both
N-terminal and C-terminal attachments, and two different fusion pro-
teins [(Cherry)4 and β-Gal]. Furthermore we made the respective GFP
control construct where the putative NLS was connected by the same
spacer and in the same orientation as to GFP-(Cherry)4 or to GFP-β-Gal
in order to reveal a possible interference with GFP.
To test whether the transport of the fusion constructs is an active
or passive process, we coupled the (25–61) fragment of Sho, the full
length Shadoo protein, NLSqki5 or the NLSx3SV40 to GFP-β-Gal as well
to the control GFP constructs (Fig. 8A) and examined their localiza-
tion in transiently transfected HeLa cells. We could not detect any
proteolytic cleavage that could separate GFP from β-Gal on Western
blots (Fig. 8A). The (25–61) fragment of Sho or the full length Sho
were not able to facilitate the nuclear targeting of the fusion construct
(data not shown in the case of Sho-GFP-β-Gal). Since the correspond-
ing ΔSS-Sho-YFP and (25–61)Sho-GFP proteins exhibited nuclear ac-
cumulation, these results do not support the involvement of Sho
in facilitated nuclear transport. By contrast, the positive control
NLSx3SV40-GFP-β-Gal exhibited nuclear targeting (Fig. 8B). Inter-
estingly, one of the positive controls, NLSqki5 showed no nuclear
targeting, and the corresponding GFP fusion protein also failed to
accumulate in the nucleus indicating an interference of NLSqki5
with GFP when attached N-terminally (data not shown).
Experiments with 5 consecutive ﬂuorescent proteins [GFP-
(Cherry)4 fusion constructs] with C-terminal attachments of the
putative NLS sequences along with the corresponding controls
gave the same results. No nuclear targeting was observed in the
case of GFP-(Cherry)4-(25–61)Sho or the negative control GFP-
(Cherry)4, however the controls—GFP-(Cherry)4-NLSSV40 and GFP-
(Cherry)4-NLSqki5—showed nuclear signals (Supp. Fig. 5).
Taking the outcome of the experiments in Sections 3.6.1 and 3.6.2
together, the results are rather surprising. The results of the experi-
ments with the large fusion proteins leave little chance for Sho to be
transported through the nuclear pore by active processes. None of the
three different constructs (with both Sho and the (25–61) fragment,
in two orientations, with two different fusion partners) were actively
transported to the nucleus although each of the corresponding GFP con-
structs showed nuclear accumulation. Thus, interference by the fusion
proteins that mask the NLS function of Sho in all three different con-
structs is rather unlikely.
However, the chilling and ATP-depletion experiments cause Sho to
equilibrate between the cytosol and the nucleus (except the nucleolus
where Sho remained bound) indicating that under these condition
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Fig. 7. Chilling and deoxy-glucose treatment of Shadoo transfected HeLa cells. (A) Effect of chilling and DEG treatment on Shadoo transfected HeLa cells (p=0.000, ***).
GFP-(Cherry)4-NLSSV40 served as a control for nuclear lamina intactness. As this construct is too large for passive entry or exit, it maintained its nuclear accumulation during treatments
indicating that the nuclear pores were intact. NLSSV40 does not mediate binding to any nuclear components in the cells that could inhibit its exit from the nucleus when the pores are
damaged—as demonstrated by a GFP-NLSSV40 construct. NLSx3SV40-GFP served as a control that possesses a nuclear retention signal and maintained its nuclear accumulation during
treatment. Accumulation ofΔSS-Sho-YFP,ΔSS-YFP-Sho and GFP-(25–61)Sho in the nucleuswas diminished except in the nucleoluswhich retained its ﬂuorescence and appeared as bright
spots; (B) Representative confocal microscopy images of HeLa cells expressing of ΔSS-YFP-Sho, ΔSS-Sho-YFP, GFP-(25–61)Sho, GFP-(Cherry)4-NLSSV40, GFP-NLSSV40 and NLSx3SV40-GFP.
Green: enhanced YFP/GFP, yellow: GFP and mCherry merged together. Scalebar represents 10 μm.
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would facilitate its accumulation. Seemingly, Sho's nuclear accumula-
tion is mediated by neither an active, nor a passive transport. Our inter-
pretation of these data is that Sho accumulates in the nucleus by a
passive transport but its binding or the presence of its binding partner
in the nucleus requires active processes (note that chilling or ATP-
depletion slows down all active processes in the cells, not just the
nuclear transport). Alternatively, under stress conditions (chilling or
ATP-depletion) modiﬁcations (such as by (de)phosphorylation or (de)
methylation) may occur on Sho or on its binding partner that prevents
them binding.
Neither newly-synthesized proteins, nor phosphorylation seems
to play a role in Sho's accumulation as neither cycloheximide nor
staurosporine treatment diminished it (data not shown). Therefore,
the mechanism of the accumulation of Sho and the identiﬁcation ofits putative binding partner in the nucleus and in the nucleolus
needs further research.
3.7. Localization of the endogenous Sho protein
Tagged versions of the Shadoo protein consistently appeared
within the nucleus in our study, however, the localization of the en-
dogenous protein is not demonstrated here. Answering this question
is rather difﬁcult in the absence of appropriate antibodies. We have
generated antibodies against ﬁve different peptides of Sho in rabbits
and hen, but only one of them seemed to show some speciﬁcity
against Shadoo (EG62). Four antibodies [EG62 and the three commer-
cially available antibodies: R-12 (Santa Cruz), S-12 (Santa Cruz),
SPRN antibody (C-term) (Abgent)] gave strong nuclear staining. We
analyzed the speciﬁcity of these antibodies in peptide competition
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Fig. 8. Subcellular localization and immune blot pattern of GFP-β-Gal fusion- and control constructs (A). Schematic structures and western blot analysis of GFP-β-Gal,
NLSx3SV40-GFP-β-Gal (NLSx3SV40 in red box) and (25-61)Sho-GFP-β-Gal (10% SDS-PAGE; anti-GFP/YFP AB 1:3.500). (B) Confocal microscopy images of HeLa cells expressing
GFP-β-Gal, NLSx3SV40-GFP-β-Gal, (25–61)Sho-GFP-β-Gal (upper images), GFP, NLSx3SV40-GFP and (25–61)Sho-GFP (lower images) [merged (blue and green): Hoescht 33342 and
GFP]. The (25–61) fragment of Sho was not able to facilitate the nuclear and nucleolar targeting of the large GFP-β-Gal fusion construct. Scalebar represents 10 μm.
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nal in cells transfected with YFP-Sho or Sho-YFP constructs (data not
shown), but the results of these experiments leave room for several
alternative interpretations. Considering these results together with
the low speciﬁcity of these antibodies as judged by Western blotting
(data not shown), we deemed these data inconclusive.
However, Daude et al. [22] could reach a conclusion regarding the sub-
cellular localization of the Shadoo protein by their antibodies using brain
tissues from Shadoo knockout mice as negative controls. Beside the
expected membrane localization, they acquired data showing deﬁned
nucleocytoplasmic staining of the endogenous Shadoo in some of the hy-
pothalamic neurons of wild-type mice. Furthermore, in contrast to the
negative controls, a portion of wild-type Shadoo was found in histone
containing fractions from subcellular separations of both brain and cul-
tured cells. During the review process of this manuscript a study was
published by Lau et al. [58] where, in line with these observations,
they proved that Shadoo indeed binds nucleic acids, further supporting
its possible role in the nuclear compartment. In addition, several
interacting partners from the nucleocytoplasmic compartment were
identiﬁed for Shadoo in a recent study [6] that is also consistent with
the nuclear accumulation of a fraction of Shadoo.
3.8. The trafﬁc of Sho to non-secretory compartments
There are a growing number of proteins that are detected in
dual (both secretory and non-secretory) localizations, however, the
transport mechanisms by which a secretory protein appears in the
nucleocytoplasmic compartment has not been clariﬁed for many of
them yet [59].
The inefﬁciency of signal peptides in directing newly-synthesized
polypeptides to the ER causes a fraction of the secretory proteins to ap-
pear in the cytosol [60]. Furthermore, retrotranslocation or escape from
ubiquitin–proteasome degradation on retrograde transport from the ER
to the cytosol has also been suggested for proteinswith dual localization
[61]. Such “mislocalized” proteins could be observed in the nucleus/
cytosol as the removal of secretory proteins from the cytosol is appar-
ently not completely effective [59]. Thus, a fraction of the endogenous
Sho likewise may appear in the nucleocytoplasmic compartment.
We also considered the effect of the overexpression on Shadoo's
nuclear localization. The overexpression of Sho may overload theER-translocation machinery or proteosomes and lead to a non-natural
nuclear localization for these Shadoo variants. However, the over ex-
pression of similar ER-targeted constructs (YFP-PrP, data not shown,
YFP-GPI or Sho-YFP) does not result in such strong cytosolic/nuclear
accumulation, arguing against a simple overload explanation. In addi-
tion, the overload effect should lead to the appearance of nuclear signals
additional to themembrane, ER and Golgi staining. By contrast, in these
experiments we commonly observed nuclear localization in cells in
which the membrane (or ER/Golgi) signals were absent seeming to
point to a distinct, speciﬁc mechanism that directs Sho to the nucleus.
3.9. Implications for the function of the prion protein family
Apparently, PrP has minor populations of different forms with
different subcellular localizations that are associated with speciﬁc
distinct functions [38,62]. For example, some 2–5% [63,64] of the
prion protein appears in a transmembrane form and exposes a part
of the otherwise extracellular GPI-anchored prion protein to the
cytosol. Although this small fraction was not detectable by im-
munocytochemistry and its existence could be revealed only by
overexpressing the prion protein [65,66] a biological function was
attributed to this small fraction [62].
This multifunctionality, which is linked to multiple subcellular lo-
cations might be a common feature of some natively disordered pro-
teins [59,67–69], such as the prion and Shadoo proteins [38,62,64,70].
Since proteins' subcellular compartmentalization is not an all or
none process [60], a few percentage of Shadoo unavoidably appears
in the nucleocytoplasmic compartment. Our ﬁnding that Shadoo has
sequences that mediate its nuclear accumulation indicates that we
have to calculate on a considerable nuclear fraction of Shadoo even
in those cells where this nuclear form of Shadoo does not reach a de-
tectable level. Further studies are needed to discern if this small frac-
tion of Shadoo with altered subcellular localization has a speciﬁc
function like the transmembrane form of the prion protein.
PrP binds to polyanions, thus its nuclear accumulation may be
rationalized on the basis of its nucleic acid binding ability. Sho also
binds nucleic acids (unpublished results and [58]), thus, its positively
charged arginine residues (Suppl. Fig. 4) may also mediate nuclear
accumulation in a similar manner. However, there are two facts
that suggest alternative explanations. First, the second half of the
1210 E. Tóth et al. / Biochimica et Biophysica Acta 1833 (2013) 1199–1211(RXXX)8 motif seems to exert a more profound effect on Sho nuclear
accumulation than the ﬁrst part containing the RGG box that encom-
pass four arginines (Figs. 3 and 5). Second, Sho seems to be involved
in different interactions in the nucleolus compared to the rest of the
nucleus (Fig. 7). These observations suggest that the interactions
that are responsible for its nuclear accumulation are rather speciﬁc
in nature.
It is intriguing that although PrP and Sho have no apparent se-
quence similarities other than about 25 amino acids around the HD
region share a feature that is apparently not related to this segment.
There are forms of and/or conditions for both proteins where they
appear in the nucleocytosolic compartment and they both contain
sequences that are capable of mediating nuclear accumulation. This
may provide considerable support to the argument that both PrP
and Sho have a function in the nucleus. A detailed analysis and compar-
ison of PrP's and Sho's nuclear localizations may reveal whether these
commonalities are circumstantial or not.
4. Conclusions
In conclusion, we detected tagged-forms of the Shadoo protein in
the nucleus of several cell lines. This nuclear accumulation seems not
to be mediated by a facilitated transport. However, under conditions
that block facilitated transport nuclear accumulation is diminished.
This may indicate a speciﬁc regulatory mechanism for Sho's nuclear
accumulation. Our results imply, in accord with data found in the
literature, that a fraction of the endogenous Shadoo protein is likely
to locate to the nucleus either of certain types of cells and/or under
certain conditions, however, whether this fraction has any function,
and if so what, remains unclear.
Sho also accumulates in the nucleolus, even under conditions that
diminish its accumulation in other parts of the nucleus suggesting a
speciﬁc binding partner there.
The nuclear accumulation of Shadoo is mediated by an N-terminal
segment of the protein encompassing (RXXX)n repeats. The (RXXX)n
motif is highly conserved and unique among the Shadoo proteins
from mammals. Whether this motif has evolved to enable a nuclear
function for these proteins is not clear.
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.bbamcr.2013.01.020.
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